For years, individuals diagnosed with polycystic ovary syndrome (PCOS) have questioned whether the name accurately captured their experience. Despite being one of the most prevalent hormonal disorders among women of reproductive age, many diagnosed with PCOS do not actually have ovarian cysts, and the symptoms often extend well beyond reproductive health.
In a significant development, the condition has been officially renamed polyendocrine metabolic ovarian syndrome (PMOS). This change aims to better represent the wide-ranging hormonal and metabolic impacts of the disorder. The announcement came this week through a paper published in The Lancet, following extensive international consultation over several years.
The World Health Organization estimates that PMOS affects approximately 10 to 13 percent of women of reproductive age worldwide, and it can also impact transgender individuals. Symptoms include irregular menstruation, acne, excessive body hair, fertility challenges, and metabolic complications.
The rationale behind the renaming is that the term “polycystic ovary syndrome” has often been misleading, as many patients diagnosed with the condition never develop ovarian cysts. Instead, the disorder is increasingly recognized as a broader hormonal and metabolic syndrome associated with insulin resistance, type 2 diabetes, and cardiovascular risks.
Professor Helena Teede, an endocrinologist who led the international initiative for the name change, explained that the condition had been “placed in the wrong box” for years due to an excessive focus on ovarian symptoms rather than the wider health implications.
The decision followed a comprehensive global review involving numerous medical organizations, researchers, and patient groups, with thousands of healthcare professionals and patients consulted throughout the process.
Importantly, the new name does not alter current diagnostic criteria or treatment protocols. However, medical professionals hope this shift will enhance awareness, reduce stigma, and promote earlier diagnosis and more holistic care.
For many patients who have long felt misunderstood, this renaming represents more than just a medical update. It signals a broader change in the understanding and perception of the condition itself.
